AK Kakkar
- Internal Medicine top 1%
- Cardiology and Cardiovascular Medicine top 10%
- Hematology top 5%
- Surgery
- Oncology
- Topics
- Venous Thromboembolism Diagnosis and Management (7 papers)HER2/EGFR in Cancer Research (3 papers)Cancer Treatment and Pharmacology (3 papers)
- Partner nations
- United Kingdom
In The Last Decade
AK Kakkar
11 papers receiving 721 citations
Peers
Comparison fields: 5 of 77
- Internal Medicine 416
- Cardiology and Cardiovascular Medicine 264
- Hematology 170
- Surgery 164
- Oncology 161
Countries citing papers authored by AK Kakkar
This map shows the geographic impact of AK Kakkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by AK Kakkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AK Kakkar more than expected).
Fields of papers citing papers by AK Kakkar
This network shows the impact of papers produced by AK Kakkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by AK Kakkar. The network helps show where AK Kakkar may publish in the future.
Co-authorship network of co-authors of AK Kakkar
This figure shows the co-authorship network connecting the top 25 collaborators of AK Kakkar. A scholar is included among the top collaborators of AK Kakkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with AK Kakkar. AK Kakkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | A Pooled Analysis of Surgical Complications: Results from the RECORD Program. | 1 |
| 2 | 1 | |
| 3 | Prevention and treatment of venous thromboembolism - International Consensus Statement (Guidelines according to scientific evidence) | 300 |
| 4 | Treatment of acute, symptomatic, proximal deep vein thrombosis with the oral, direct Factor Xa inhibitor rivaroxaban (BAY 59-7939) - the ODIXa-DVT dose-ranging study | 9 |
| 5 | Antithrombotic therapy with low molecular weight heparin in cancer patients. | 5 |
| 6 | 11 | |
| 7 | A Randomized trial of long term dalteparin low molecular weight heparin (LMWH) versus oral anticoagulant (OA) therapy in cancer patients with venous thromboembolism (VTE). | 13 |
| 8 | 296 | |
| 9 | 84 | |
| 10 | Thrombomodulin expression of primary breast cancer is a predicttor of axillary lymph node metastasis | 1 |
| 11 | 34 |
About AK Kakkar
AK Kakkar is a scholar working on Internal Medicine, Oncology and Hematology, having authored 11 papers that have together received 755 indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (7 papers), HER2/EGFR in Cancer Research (3 papers) and Cancer Treatment and Pharmacology (3 papers). The work is most often cited by research in Internal Medicine (416 citations), Hematology (170 citations) and Cardiology and Cardiovascular Medicine (264 citations). AK Kakkar has collaborated with scholars based in United Kingdom. Frequent co-authors include GF Nash, M F Scully, Kakkar Vv, M Samama, Michiels Jj, Russel Hull, Goldhaber Sz, Jawed Fareed, Arthur A. Sasahara and K Myers. Their work appears in journals such as Blood, The Lancet Oncology and Journal of Thrombosis and Haemostasis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.